Proactive Investors - Run By Investors For Investors

Chemistree Technology unveils plans for debenture offering

The debentures will mature three years from the date of issue and the debenture units will also consist of 2,000 company share purchase warrants
Businessman looking at financial charts
The company is set for a debenture unit offering

Chemistree Technology Inc (CSE:CHM) (OTCMKTS: CHMJF)  is set for an offering of convertible debenture units and has appointed broker Canaccord as the sole bookrunner.

In a short form prospectus, the firm said each debenture unit will consist of one 10% unsecured convertible debenture of the company worth $1,000 with interest payable semi-annually in arrears on June 30 and December 31 of each year, beginning June 30 this year.

WATCH: Chemistree Technology preparing to build greenhouse and production facility in Cali

The debentures will mature three years from the date of issue and the debenture units will also consist of 2,000 company share purchase warrants expiring 36 months after the date of issue.

Each debenture is convertible at $0.50 per share subject to certain adjustments, while each warrant allows the holder one share at an exercise price of $0.70 per share until the expiry date.

The debentures and the warrants comprising the debenture units will separate immediately upon the closing of the offering.

There is no minimum amount of funds that must be raised under the offering, the company noted.

Contact Giles at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

1542134062_Harvesting-hemp.jpg
November 13 2018
Ascent, viaThirty Eight Hemp Corp, will exploit the hemp market via its strategic relationship with AgTech Scientific
amberlight
Tue
The cannabis company's strategy is to focus solely on the massive California market, where it plans to establish a network of dispensaries with owner-operators
cannabis bud on tray
April 25 2019
Armed with a new partnership with Canada's largest pharmacy and an international cultivator, Flowr is aiming to provide medicinal and recreational consumers around the world with premium, high-quality cannabis
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use